Results     29-May-17
Announcements
Marksans Pharma standalone net profit declines 88.78% in the March 2017 quarter
Sales decline 22.30% to Rs 53.95 crore
Net profit of Marksans Pharma declined 88.78% to Rs 0.57 crore in the quarter ended March 2017 as against Rs 5.08 crore during the previous quarter ended March 2016. Sales declined 22.30% to Rs 53.95 crore in the quarter ended March 2017 as against Rs 69.43 crore during the previous quarter ended March 2016.

For the full year,net profit declined 82.89% to Rs 12.23 crore in the year ended March 2017 as against Rs 71.49 crore during the previous year ended March 2016. Sales declined 39.73% to Rs 215.84 crore in the year ended March 2017 as against Rs 358.13 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Ended
 Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.
Sales53.9569.43 -22 215.84358.13 -40
OPM %7.4310.41 -11.2129.01 -
PBDT3.0812.80 -76 27.58106.39 -74
PBT-0.748.41 PL 12.5891.64 -86
NP0.575.08 -89 12.2371.49 -83

Previous News
  Marksans Pharma to convene board meeting
 ( Corporate News - 04-Aug-23   14:03 )
  Marksans Pharma arm receives UK MHRA marketing authorization for Levetiracetam Relonchem
 ( Corporate News - 28-May-24   12:08 )
  Marksans Pharma spurts as Q2 PAT rises 30% YoY
 ( Hot Pursuit - 15-Nov-22   10:42 )
  Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   12:11 )
  Marksans Pharma spurts after Q4 PAT leaps 191% YoY to Rs 82 cr
 ( Hot Pursuit - 30-May-23   15:39 )
  Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   11:21 )
  Marksans Pharma to consider buyback
 ( Corporate News - 05-Jul-22   09:52 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 28-Jan-21   19:30 )
  Marksans Pharma standalone net profit declines 53.52% in the September 2017 quarter
 ( Results - Announcements 13-Nov-17   15:59 )
  Marksans Pharma rises after subsidiary receives EIR from US FDA
 ( Hot Pursuit - 03-Nov-23   13:14 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 08-Nov-18   14:06 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top